The contract is for 400 million doses of the vaccine, which was developed with the University of Oxford and whose experimentation phase is already advanced and expected to end in autumn, Roberto Speranza said in a Facebook post.from Moneycontrol Business News https://ift.tt/2XVZIiY
No comments:
Post a Comment